Version 5.4
Bos taurus Protein: EEF1B
Summary
InnateDB Protein IDBP-695970.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol EEF1B
Protein Name Elongation factor 1-beta
Synonyms EEF1B;
Species Bos taurus
Ensembl Protein ENSBTAP00000029304
InnateDB Gene IDBG-643415 (EEF1B)
Protein Structure
UniProt Annotation
Function EF-1-beta and EF-1-delta stimulate the exchange of GDP bound to EF-1-alpha to GTP. {ECO:0000250}.
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 47 interaction(s) predicted by orthology.
Predicted by orthology
Total 47 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003746 translation elongation factor activity
GO:0005515 protein binding
Biological Process
GO:0006412 translation
GO:0006414 translational elongation
Cellular Component
GO:0005853 eukaryotic translation elongation factor 1 complex
Protein Structure and Domains
PDB ID
InterPro IPR010987 Glutathione S-transferase, C-terminal-like
IPR014038 Translation elongation factor EF1B, beta/delta subunit, guanine nucleotide exchange
IPR018940 Elongation factor 1 beta central acidic region, eukaryote
PFAM PF00736
PF10587
PRINTS
PIRSF
SMART SM00888
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q5E983
PhosphoSite PhosphoSite-
TrEMBL
UniProt Splice Variant
Entrez Gene 520875
UniGene
RefSeq NP_001014936
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL AY911340 BC147944 BT021037
GenPept AAI47945 AAW82108 AAX09054

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca